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ABSTRACT
Marijuana has been included in the list of illicit drugs for a long time despite its use as a remedy for several medical 
problems. However this use has been on the basis of the individual experiences with no concrete scientiﬁc 
evidence. Its positive effects have been mostly overshadowed by its recreational use worldwide. It has recently 
become the topic of hot debate due to several studies showing its role in various medical and especially 
neurological disorders. These new ﬁndings have created a controversy and world is still divided on its legalization 
for medicinal purpose. Several countries and states have legalized it recently, but many experts have raised 
concerns about its misuse and long term legal, ethical, ﬁnancial and health implication, that need to be answered 
yet. Pakistan is considered as one of the largest cannabis producing country and with increasing evidence for 
potential medicinal beneﬁts; we need to develop a consensus on this topic, considering health, legal and ethical 
perspectives linked to its medical uses in our society.
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INTRODUCTION:
To date, about 86 Cannabinoid compounds have 
been identiﬁed in nature and some other are 
synthesized chemically. They have been mostly used 
for recreational purposes with major psychoactive 
ingredient being delta-g-tetrahydrocannabinol (THC) 
and some of these compounds like dronabinol and 
1
nabilone have been used as prescription drugs .
Cannabis has been used for various therapeutic 
purposes for thousand of the years. Initially it was 
grown as an agricultural crop called Hemp, in China 
which then traveled through Asia into Middle East and 
Africa where it was used for pain and other various 
conditions like gout, malaria, Rheumatism, and poor 
memory for a long time alongside its use for 
2
recreational purposes as well .
 In 1970, it was categorized as Schedule 1 drug and 
was listed as having no accepted medical use and 
further research was restricted until recently where it 
was found to be of several uses and less side effects 
2 
than previously documented . These ﬁndings have 
lead to its legalization for medical purposes in April 
2015 in about 23 states of USA. Several other 
countries including Holland, Germany, Spain France, 
Colombia, Czech Republic, Canada have legalized 
its use for medicinal purpose.According to a study, in 
USA about 17% of past-year marijuana users 
3
reported its use for medical purposes recently . 
USES OF  CANNABINOIDS IN  VARIOUS 
NEUROLOGICAL DISORDERS:
Currently, pill form of “dronabinol” and “nabilone” 
has received FDA approval only for nausea caused 
by chemotherapy and to increase the appetite of 
4
people with AIDS . Various studies have shown its 
beneﬁcial effects in several neurological disorders 
recently. For some indications, signiﬁcant data has 
been found to recommend its use where traditional 
therapies were not found to be effective while for 
several other disorders its use is still on the 
experimental basis and we still have insufﬁcient 
evidence to use it.
1. INDICATIONS WITH GOOD EVIDENCE:
Epilepsy: Dronabinol and Nabilone have been 
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found beneﬁcial in various childhood onset epilepsies 
including Dravet and Lennox-Gastaut syndromes 
that are resistant to the traditional therapies. Their 
addition may reduce median monthly seizure 
5
frequency by about 36.5% . They were also found 
useful in the management of super refractory status 
6.
epilepticus  But we still need evidence to recommend 
it as alternative to traditional antiepileptics in more 
common epilepsies and as a ﬁrst line agent in drug 
resistant epilepsies.
Multiple Sclerosis:Cannabinoids (nabilone and 
nabiximols) have been found useful for various 
symptoms of multiple sclerosis like pain, spasticity 
7
and urinary dysfunction . Although these indication 
have not got FDA approval, health agencies like 
American Academy of Neurology (AAN) recommend 
that it can be considered in suitable patients as 
8
alternative to typical therapies .
Neuropathic and other type of pain:These may 
provide effective analgesia in conditions that are 
refractory to other treatments including refractory 
neuropathic pain cause by diabetes mellitus, central 
neuropathic pain, pain in cancer patients, and in HIV-
positive patients. According to a study about 90% of 
patients reported an improvement in nerve pain after 
9
cannabis use . Several guidelines recommend its use 
when traditional therapies are not helpful.
Depression and anxiety: Data about anxiety 
suggested a greater beneﬁt of cannabinoids 
(dronabinol, nabilone, and nabiximols) than placebo 
10
and can be consider for suitable patients . However 
no difference between cannabinoids and placebo in 
outcomes of depression was seen and some reported 
a negative effect at high doses.
Tics and Tourette syndrome:There is insufﬁcient 
evidence to support or refute the clinical use of 
cannabis for tics. However, it could be an option in 
resistant cases as positive effects of THC were seen 
11
in few studies .  
2 .  I N D I C AT I O N S  W I T H  BE N E F I T S  BU T 
INSUFFICIENT EVIDENCE:
Dementia:Recently few studies have found that 
tetrahydrocannabinol and other compounds may 
12
reduce B-Amyliod in the brain . A recent study has 
concluded that cannabis extract containing THC can 
relieve various cognitive and psychiatric symptoms of 
Alzheimer's diseaseand found them to be safe and 
13
promising treatment option .However more data is 
required for its use in dementia clinically. 
Parkinson's disease:It has been studied in the 
context of improving motor features, functional 
outcomes and in dopa related dyskinesiaswith mixed 
11
results . Evidence is needed for its recommendation 
for these and target symptoms (e.g. dystonia, 
psychosis, sleep) related to Parkinson's disease. 
Huntington's disease:Although limited data is 
available to recommend its use in Huntington's 
disease but various case series and small studies 
showed signiﬁcant improvements  in chorea and the 
neuropsychiatric symptoms in patients with 
Huntington's disease. Further large scale studies 
may be needed to ﬁnd its usefulness for these 
11
indications .
Dystonia: Data for its use in dystonia is limited to few 
small randomized placebo-controlled clinical trials 
with mixed results. Further large studies are needed 
11
to clear its role . 
(Amyotrophic Lateral sclerosis (ALS): Some studies 
showed that theymight be helpful in some aspects in 
ALS patients like delaying the onset of ALS and 
slowing the progression. Thesemight also help to 
manage pain, appetite loss, depression, sleep 
14
problems, spasticity and drooling . However more 
evidence is needed for recommendation of its use in 
ALS.
Migraine: They have been found to inhibit pain 
response in migraine patients, but clinical trials are 
15
needed to recommend its use for this indication .
Prion disease: On the experimental basis they have 
shown to reduce the risk of prion disease and protect 
from prion toxicity but still need to be tested 
16
clinically .
Stroke: They seem to reduce the infarct size and 
improve functional, histological and neurobehavioral 
recovery but no large scale data is available for its 
17
recommendation .
Sleep disorders: There was some evidence that 
cannabinoids may improve sleep in some patients. 
Cannabinoids were associated with a greater 
average improvement in sleep quality and sleep 
18
disturbance than the placebo . Further large scale 
studies are needed to ﬁnd its beneﬁt for this purpose.
Other uses: Some studies have shown its anti tumor 
activity, as it showed to inhibit growth of the cancer 
cells. Its beneﬁts have also been observed in Spinal 
19
cord injury and Fibromyalgia as well .
Despite signiﬁcant positive data, several factors pose 
a challenge to its use as a medicine. These include 
Medical, ethical and legal and economical factors.  
Medically it is found to be much safer to traditional 
pharmacological agents and addictive potential of 
cannabis is quite low. The risk of dependence on 
cannabis is reported to be 9% in long-term users, 
signiﬁcantly less than the addic on rates of heroin, 
20
cocaine, alcohol, and prescribed anxioly cs  Its side eﬀect 
proﬁle includes euphoria, disorienta on, drowsiness, 
dizziness, motor in coordina on, and poor concentra on. 
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The peripheral adverse effects include tachycardia, 
hypotension, conjunctival injection, bronchodilation, 
muscle relaxation, and decreased gastrointestinal 
motility. Long term effects include risk of psychiatric 
disorders, apathy and cognitive impairment and 
21
hazards related to pregnancy . So its use should be 
based on the beneﬁt outweigh the risk assessed by 
an expert.
Ethically in various cultures a negative image is linked 
to its use and possession. Good awareness 
campaign may help patients, their families and 
societies to make a decision based on evidence and 
knowledge. Ultimately, the medical cannabis debate 
is not about making it widely available for a broad 
range of health conditions but about giving a small 
number of patients an option where they may have 
none. 
Legally in Pakistan under The Anti-Narcotic policy 
22
2010 , person may get punishment up to 6 months on 
possessing the cannabis, but still it is the most 
commonly used drug with prevalence of recreational 
23
use being 3.6 % in our population . Due to increasing 
argumentation for its use for medicinal purpose, like 
the  o ther  many deve loped count r ies  law 
amendments will be needed for relaxation regarding 
its use for medicinal purpose in Pakistan. 
Various necessary measures should be taken for its 
controlleduse that may include: 
(1) Only be prescribed by experts. 
(2)  Speciﬁc registered points with monitoring 
 units to monitor the dose or amount each 
 time. 
(3)  Regular follow ups by experts to monitor side  
 effects and check the possibility of misuse.
(4)  When to stop or taper the use in case of 
 negative effects.
Law amendments will be important as there is risk 
that if its judicious use is not legalized then patients 
may start acquiring it from illegal ways, which might 
lead to the poor quality and uncontrolled use opening 
ways for more hazards than bringing the good.
CONCLUSION:
Cannabinoids have been found useful in many 
neurological and medical disorders. To keep its 
use judicious and controlled, a frame work by the 
health authorities in collaboration with law 
agencies should be made so that it might be 
available when other hopes are lost and its use is 
justiﬁable and  only under a strict protocol. The 
three forces scientiﬁc knowledge, social and 
political acceptance and legislation may help to 
reach a consensus about its medicinal use.  
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